5 TABLE OF CONTENTS CHAPTER 1 General introduction and outline of the thesis Part I: Evaluation of complications in atrial fibrillation management CHAPTER 2 Efficacy and safety of direct oral anticoagulants in patients undergoing elective electrical cardioversion: A real-world patient population International Journal of Cardiology 2021;326:98-102 (first author) CHAPTER 3 Minimally interrupted novel oral anticoagulant versus uninterrupted vitamin K antagonist during atrial fibrillation ablation Journal of Interventional Cardiac Electrophysiology 2018;53:3416 (first author) CHAPTER 4 Impact of undiagnosed obstructive sleep apnea on atrial fibrillation recurrence following catheter ablation IJC Heart&Vasculature 2022;40:101014 (first author) EDITORIAL Undiagnosed sleep apnea in patients with atrial fibrillation: an underutilized opportunity for antiarrhythmic management IJC Heart&Vasculature 2022;40:101050 Part II: Evaluation of complications in device therapy CHAPTER 5 Pocket hematoma after pacemaker or defibrillator surgery: Direct oral anticoagulants versus vitamin K antagonists IJC Heart&Vasculature 2022;39:101005 (first author) CHAPTER 6 Device infection in patients undergoing pacemaker or defibrillator surgery: risk stratification using the PADIT-score Journal of Interventional Cardiac Electrophysiology 2024 (first author) CHAPTER 7 Efficacy and safety of transvenous lead extraction using a liberal combined superior and femoral approach Journal of Interventional Cardiac Electrophysiology 2021;62:23948 (fifth author)
RkJQdWJsaXNoZXIy MTk4NDMw